Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia. (2015)

First Author: Dorigatti I

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2015.05.059

PubMed Identifier: 26051515

Publication URI: http://europepmc.org/abstract/MED/26051515

Type: Journal Article/Review

Volume: 33

Parent Publication: Vaccine

Issue: 31

ISSN: 0264-410X